Meyka Pro banner
Soiken Holdings Inc.

Soiken Holdings Inc. Fundamental Analysis (JPX: 2385.T)

2385.TJPX
HealthcareBiotechnology
¥225.00
¥0.00(0.00%)
Japanese Market opens in 10h 48m

Soiken Holdings Inc. Fundamental Analysis (JPX: 2385.T)

Soiken Holdings Inc. (JPX: 2385.T) shows weak financial fundamentals with a PE ratio of 27.59, profit margin of 5.48%, and ROE of 3.50%. The company generates $3.9B in annual revenue with N/A year-over-year growth of N/A.

Key Strengths

Cash Position96.48%
PEG Ratio0.11
Current Ratio8.98

Areas of Concern

ROE3.50%
Operating Margin7.12%
We analyze 2385.T's fundamental strength across five key dimensions.

The stock receives a Fundamental Health Score of 47.0/100 based on profitability, valuation, growth, and balance sheet metrics. The D grade reflects weak fundamentals and significant financial concerns.

Fundamental Health Score

D
47.0/100

We analyze 2385.T's fundamental strength across five key dimensions:

Efficiency Score

Weak

2385.T struggles to generate sufficient returns from assets.

ROA > 10%
3.10%

Valuation Score

Moderate

2385.T shows balanced valuation metrics.

PE < 25
27.59
PEG Ratio < 2
0.11

Growth Score

Moderate

2385.T shows steady but slowing expansion.

Revenue Growth > 5%
N/A
EPS Growth > 10%
N/A

Financial Health Score

Excellent

2385.T maintains a strong and stable balance sheet.

Debt/Equity < 1
0.00
Current Ratio > 1
8.98

Profitability Score

Weak

2385.T struggles to sustain strong margins.

ROE > 15%
3.50%
Net Margin ≥ 15%
5.48%
Positive Free Cash Flow
No

Key Financial Metrics

Is 2385.T Expensive or Cheap?

P/E Ratio

2385.T trades at 27.59 times earnings. This indicates a fair valuation.

27.59

PEG Ratio

When adjusting for growth, 2385.T's PEG of 0.11 indicates potential undervaluation.

0.11

Price to Book

The market values Soiken Holdings Inc. at 0.96 times its book value. This may indicate undervaluation.

0.96

EV/EBITDA

Enterprise value stands at 43.54 times EBITDA. This signals the market has high growth expectations.

43.54

How Well Does 2385.T Make Money?

Net Profit Margin

For every $100 in sales, Soiken Holdings Inc. keeps $5.48 as profit after all expenses.

5.48%

Operating Margin

Core operations generate 7.12 in profit for every $100 in revenue, before interest and taxes.

7.12%

ROE

Management delivers $3.50 in profit for every $100 of shareholder equity.

3.50%

ROA

Soiken Holdings Inc. generates $3.10 in profit for every $100 in assets, demonstrating efficient asset deployment.

3.10%

Following the Money - Real Cash Generation

Operating Cash Flow

Soiken Holdings Inc. generates limited operating cash flow of $0.00, signaling weaker underlying cash strength.

$0.00

Free Cash Flow

Soiken Holdings Inc. generates weak or negative free cash flow of $0.00, restricting financial flexibility.

$0.00

FCF Per Share

Each share generates $0.00 in free cash annually.

$0.00

FCF Yield

2385.T converts 0.00% of its market value into free cash.

0.00%

Financial Ratios Analysis

Valuation Ratios

P/E Ratio

Price to earnings ratio

27.59

vs 25 benchmark

PEG Ratio

Price/earnings to growth ratio

0.11

vs 25 benchmark

P/B Ratio

Price to book value ratio

0.96

vs 25 benchmark

P/S Ratio

Price to sales ratio

1.51

vs 25 benchmark

Financial Health

Debt/Equity

Total debt to shareholders' equity

0.00

vs 25 benchmark

Current Ratio

Current assets to current liabilities

8.98

vs 25 benchmark

Efficiency Ratios

ROE

Return on equity percentage

0.03

vs 25 benchmark

ROA

Return on assets percentage

0.03

vs 25 benchmark

ROCE

Return on capital employed

0.05

vs 25 benchmark

How 2385.T Stacks Against Its Sector Peers

Metric2385.T ValueSector AveragePerformance
P/E Ratio27.5932.14 Better (Cheaper)
ROE3.50%550.00% Weak
Net Margin5.48%30133.00% Weak
Debt/Equity0.000.56 Strong (Low Leverage)
Current Ratio8.985.70 Strong Liquidity
ROA3.10%3.00% Neutral

2385.T outperforms its industry in 3 out of 6 key metrics, but lagging in ROE.

Historical Growth Performance

5-Year Growth Trajectory

This section reviews Soiken Holdings Inc.'s 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.

Revenue CAGR

N/A

Industry Style: Defensive, Growth, Innovation

EPS CAGR

N/A

Industry Style: Defensive, Growth, Innovation

FCF CAGR

N/A

Industry Style: Defensive, Growth, Innovation

Fundamental Analysis FAQ